0001235802-22-000111.txt : 20220915 0001235802-22-000111.hdr.sgml : 20220915 20220915164128 ACCESSION NUMBER: 0001235802-22-000111 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220913 FILED AS OF DATE: 20220915 DATE AS OF CHANGE: 20220915 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Daves Julie VanOrsdel CENTRAL INDEX KEY: 0001945603 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36291 FILM NUMBER: 221246196 MAIL ADDRESS: STREET 1: 301 CARLSON PARKWAY, SUITE 210 CITY: MINNEAPOLIS STATE: MN ZIP: 55305 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: DiaMedica Therapeutics Inc. CENTRAL INDEX KEY: 0001401040 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: Z4 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: TWO CARLSON PARKWAY STREET 2: SUITE 260 CITY: MINNEAPOLIS STATE: MN ZIP: 55447 BUSINESS PHONE: (763) 496-5454 MAIL ADDRESS: STREET 1: TWO CARLSON PARKWAY STREET 2: SUITE 260 CITY: MINNEAPOLIS STATE: MN ZIP: 55447 FORMER COMPANY: FORMER CONFORMED NAME: DiaMedica Inc. DATE OF NAME CHANGE: 20070525 4 1 primary_doc.xml PRIMARY DOCUMENT X0306 4 2022-09-13 0 0001401040 DiaMedica Therapeutics Inc. DMAC 0001945603 Daves Julie VanOrsdel 301 CARLSON PARKWAY, SUITE 210 MINNEAPOLIS MN 55305 0 1 0 0 SVP Clinical Development Oper. Voting Common Shares, no par value per share 0 D Stock Option (right to buy) 1.47 2022-09-13 4 A 0 140000 0 A 2032-09-12 Common Shares 140000 140000 D This option vests with respect to 35,000 common shares on September 13, 2023 and with respect to the remaining 75% of the common shares in 36 nearly equal monthly installments commencing one month after the one-year anniversary of the grant date. /s/ Amy Culbert, attorney-in-fact 2022-09-15